Clinical Trials Browser

Bile Duct Neoplasms × durvalumab × 90 days × Clear all

NCT05712356 2026-05-26

BOLSTER

Phase 2 Terminated

66 enrolled 12 charts

Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma, Disease Progression

NCT06274879 2026-05-26

Ablatio

Phase 2 Recruiting

Gastrointestinal

Bile Duct Neoplasms

NCT05655949 2026-04-22

Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio

Phase 2 Recruiting

Gastrointestinal

Bile Duct Neoplasms, Cholangiocarcinoma